H
2.31
-0.05 (-2.12%)
| Previous Close | 2.36 |
| Open | 2.40 |
| Volume | 2,648,367 |
| Avg. Volume (3M) | 4,989,145 |
| Market Cap | 358,324,896 |
| Price / Sales | 555.64 |
| Price / Book | 9.94 |
| 52 Weeks Range | |
| Earnings Date | 11 Aug 2025 - 15 Aug 2025 |
| Operating Margin (TTM) | -4,484.33% |
| Diluted EPS (TTM) | -0.690 |
| Total Debt/Equity (MRQ) | 228.93% |
| Current Ratio (MRQ) | 3.68 |
| Operating Cash Flow (TTM) | -99.38 M |
| Levered Free Cash Flow (TTM) | -67.40 M |
| Return on Assets (TTM) | -42.82% |
| Return on Equity (TTM) | -249.75% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bearish | Bearish |
| Biotechnology (Global) | Bearish | Bearish | |
| Stock | Humacyte, Inc. | Bearish | Bullish |
AIStockmoo Score
1.3
| Analyst Consensus | 4.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.5 |
| Average | 1.25 |
|
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 20.16% |
| % Held by Institutions | 39.89% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Monashee Investment Management Llc | 31 Mar 2025 | 2,000,000 |
| Maven Securities Ltd | 31 Mar 2025 | 1,049,828 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 25.00 (D. Boral Capital, 982.25%) | Buy |
| Median | 14.00 (506.06%) | |
| Low | 4.00 (HC Wainwright & Co., 73.16%) | Buy |
| Average | 14.33 (520.35%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 2.10 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| D. Boral Capital | 09 Jun 2025 | 25.00 (982.25%) | Buy | 2.56 |
| 13 May 2025 | 25.00 (982.25%) | Buy | 1.73 | |
| Benchmark | 14 May 2025 | 14.00 (506.06%) | Buy | 1.87 |
| HC Wainwright & Co. | 14 May 2025 | 4.00 (73.16%) | Buy | 1.87 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |